Daisuke Nakada Stem Cells & Regenerative Medicine Center Baylor College of Medicine Biography Publications Institution JoVE Articles Daisuke Nakada has not added a biography. If you are Daisuke Nakada and would like to personalize this page please email our Author Liaison for assistance. Publications ERα Promotes Murine Hematopoietic Regeneration Through the Ire1α-mediated Unfolded Protein Response ELife. Feb, 2018 | Pubmed ID: 29451493 ENLightening YEATS in Antagonizing Polycomb Repression Blood. Feb, 2018 | Pubmed ID: 29438969 Transcriptional and Microenvironmental Regulation of Lineage Ambiguity in Leukemia Frontiers in Oncology. 2017 | Pubmed ID: 29164065 Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9 Cell Reports. 10, 2016 | Pubmed ID: 27783956 Cell Intrinsic and Extrinsic Regulation of Leukemia Cell Metabolism International Journal of Hematology. Jun, 2016 | Pubmed ID: 26897135 AMPK Protects Leukemia-Initiating Cells in Myeloid Leukemias from Metabolic Stress in the Bone Marrow Cell Stem Cell. Nov, 2015 | Pubmed ID: 26440282 Bmi1 is Required for the Initiation of Pancreatic Cancer Through an Ink4a-independent Mechanism Carcinogenesis. Jul, 2015 | Pubmed ID: 25939753 The Role of the Lkb1/AMPK Pathway in Hematopoietic Stem Cells and Leukemia Critical Reviews in Oncogenesis. 2014 | Pubmed ID: 25404152 Prospective Identification of Functionally Distinct Stem Cells and Neurosphere-initiating Cells in Adult Mouse Forebrain ELife. May, 2014 | Pubmed ID: 24843006 Oestrogen Increases Haematopoietic Stem-cell Self-renewal in Females and During Pregnancy Nature. Jan, 2014 | Pubmed ID: 24451543 The Cytosolic Protein G0S2 Maintains Quiescence in Hematopoietic Stem Cells PloS One. 2012 | Pubmed ID: 22693613 Interrupción génica altamente eficiente de las células progenitoras hematopoyéticas murinas y humanas por CRISPR/Cas9 Lorenzo Brunetti*1,2,3, Michael C. Gundry*1,2,4, Ayumi Kitano4, Daisuke Nakada1,2,4, Margaret A. Goodell1,2,4,5 1Stem Cells & Regenerative Medicine Center, Baylor College of Medicine, 2Center for Cell and Gene Therapy, Baylor College of Medicine, 3Centro di Ricerca Emato-Oncologica (CREO), University of Perugia, 4Department of Molecular & Human Genetics, Baylor College of Medicine, 5Texas Children's Hospital & Houston Methodist Hospital JoVE 57278 Genetics
Interrupción génica altamente eficiente de las células progenitoras hematopoyéticas murinas y humanas por CRISPR/Cas9 Lorenzo Brunetti*1,2,3, Michael C. Gundry*1,2,4, Ayumi Kitano4, Daisuke Nakada1,2,4, Margaret A. Goodell1,2,4,5 1Stem Cells & Regenerative Medicine Center, Baylor College of Medicine, 2Center for Cell and Gene Therapy, Baylor College of Medicine, 3Centro di Ricerca Emato-Oncologica (CREO), University of Perugia, 4Department of Molecular & Human Genetics, Baylor College of Medicine, 5Texas Children's Hospital & Houston Methodist Hospital JoVE 57278 Genetics
